Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
- PMID: 32807701
- PMCID: PMC7428424
- DOI: 10.1016/j.ebiom.2020.102947
Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
Conflict of interest statement
Declaration of Interests The author declares no conflict of interest.
Comment on
-
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.EBioMedicine. 2020 Aug;58:102911. doi: 10.1016/j.ebiom.2020.102911. Epub 2020 Jul 22. EBioMedicine. 2020. PMID: 32711254 Free PMC article.
References
-
- Palestino G., García-Silva I., González-Ortega O., Rosales-Mendoza S. Can nanotechnology help in the fight against COVID-19? Expert Rev Anti Infect Ther. 2020:1–16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
